Diagnostic and Interventional Cardiology

Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap.

News | EP Mapping and Imaging Systems

Vektor Medical to Present Positive Results from vMap Clinical Validation Study

April 29, 2022 – Vektor Medical has announced positive results from its “Vektor vMap Clinical Validation Study” ...

April 29, 2022

Aurora St. Luke’s Medical Center in Milwaukee is the first site in the country to join a clinical trial studying machine-learning software designed to help novice users perform an echocardiography exam.

News | Cardiovascular Ultrasound

Study Evaluates AI Software that Aids Novice Users Performing Echocardiogram

April 29, 2022 – Aurora St. Luke’s Medical Center in Milwaukee is the first site in the country to join a clinical trial ...

April 29, 2022

News | Cardiovascular Business

GE Healthcare and Medtronic Announce Collaboration to Meet Growing Need for Outpatient Care

April 29, 2022 – Providing excellent care inside and outside of the traditional hospital is the new normal for patients ...

April 29, 2022

Sponsored Content

Patient applying a Cardiac Insight Cardea SOLO monitoring device at home. The remote, physician-prescribed and patient self-applied device is worn for a specified period of monitoring time and then returned to the physician office for report creation.

Feature | Atrial Fibrillation

Increasing Early Detection of Atrial Fibrillation Through Improved Short-Term Monitoring

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...

December 07, 2021

HIMSS22 showed that the industry is back on track, with leading organizations showcasing solutions for staff shortages and related burnout, cybersecurity, digital transformation, image convergence and efficiency

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Reimagining Health at HIMSS22

You could feel the energy and excitement at the 2022 HIMSS Global Health Conference & Exhibition (HIMSS22) held this ...

April 29, 2022

Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo

News | Pharmaceuticals

FDA Approves Bristol Myers' Camzyos (mavacamten) Oral Heart Disease Drug

April 29, 2022 — Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos ...

April 29, 2022

During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a technological research and consulting firm, presented the trends and top predictions in healthcare and life sciences for 2022.

Blog | Cardiovascular Business

The Digital Divide

During a Philips international media roundtable at HIMSS22, Mandi Bishop, vice president analyst at Gartner, a ...

April 29, 2022

Sponsored Content

Cardiovascular Ultrasound Analytics Aids Re-accreditation Process

Feature | Analytics Software

The Benefits of Data Analytics in Clinical Reporting

Accurate reporting is essential to producing the reliable analytics needed to meet lab accreditation standards. This is ...

October 27, 2021

The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that patients who have the Medtronic Heartware Ventricular Assist Device (HVAD) System and appear to present with pump thrombosis may have a welding defect in the internal pump causing the pump to malfunction.

News | Ventricular Assist Devices (VAD)

FDA Alert: Potential for Internal Pump Malfunction in the Medtronic HVAD System

April 28, 2022 — The U.S. Food and Drug Administration (FDA) is alerting healthcare providers to the possibility that ...

April 28, 2022

Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce major cardiovascular events, according to a new study published in the journal Radiology: Cardiothoracic Imaging.

News | CT Angiography (CTA)

Aspirin Does Not Cut Risk in Non-Obstructive Coronary Artery Disease

April 28, 2022 — Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce ...

April 28, 2022

Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), announced new measures that will allow consumers to more easily find the right form of quality, affordable health care coverage on HealthCare.gov that best meets their needs.

News | Cardiovascular Business

HHS Announces New Policy to Make Coverage More Accessible and Affordable for Millions of Americans in 2023

April 28, 2022 — Today, the Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid ...

April 28, 2022

Sponsored Content

Feature | Cardiovascular Information Systems (CVIS)

Improving Consistency and Standardization With Structured Reporting

Jeff Rieder M.D., a cardiologist with Coastal Cardiology Charleston, clearly recalls the time when reporting was ...

July 26, 2021

News | Drug-Eluting Balloons

IN.PACT AV Drug-Coated Balloon First and Only to Show Sustained and Superior Performance Compared to PTA Through 36 Months

April 27, 2022 – Medtronic has announced new randomized controlled data demonstrating the sustained and superior ...

April 27, 2022

This ERC Advanced Grant is awarded to scientists with more than ten years of research experience who have already played a prominent role in their field.

News | Heart Failure

MDC Receives ERC Advanced Grant for Cardiac Research

April 27, 2022 – The contractile and elastic properties of the heart are finely tuned. This is a prerequisite for the ...

April 27, 2022

Omega Medical Imaging has announced the release of the revolutionary Soteria.AI.

News | Interventional Radiology

Omega Introduces Soteria.AI Interventional Cardiology System

April 27, 2022 – Omega Medical Imaging has announced the release of the revolutionary Soteria.AI. Designed specifically ...

April 27, 2022

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Mining Cardiology Data to Optimize Patient Care and Improve Productivity

During the COVID-19 pandemic, many cardiology departments were faced with the daunting task of supporting inpatient and ...

June 18, 2021

Medtronic Harmony FDA recall The FDA has identified this as a Class I recall, the most serious type of recall

News | Heart Valve Technology

Medtronic Recalls Harmony Delivery Catheter, Part of TPV System, for Risk of Capsule Break During Use

April 27, 2022 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall for the Medtronic Harmony ...

April 27, 2022

CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise, high-fidelity electrograms, announced the completion of patient enrollment in the CathVision ECGenius System clinical evaluation study at the University of Vermont Medical Center.

News | EP Lab

CathVision Announces Completion of Patient Enrollment at First U.S. Clinical Trial Evaluating High-Fidelity, Low-Noise EP Recording Technology

April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

April 27, 2022

The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose aspirin therapy for the primary prevention of cardiovascular disease in adults

News | Stroke

New USPSTF Guidance: Continue to Take Low-Dose Aspirin if you have a History of Heart Attack, AFib, Stroke or Vascular Stenting

April 27, 2022 – The U.S. Preventive Services Task Force (USPSTF) has released its final recommendations on low-dose ...

April 27, 2022